Abstract
Concomitant HIV and hepatitis C virus (HCV) is a common yet complex coinfection. The present document is a practical guide for treating HCV infection in people coinfected with HIV. Effective antiretroviral therapies have prolonged survival rates for HIV-infected people over the past decade, which have made latent complications of HCV major causes of morbidity and mortality in these patients. Advances in the treatment of HCV (eg, combined pegylated interferon and ribavirin) offer the possibility of eradicating HCV infection in coinfected persons. The treatment of HCV must be considered in all cases. Intensive management of the adverse effects of HCV treatment is one of the factors for the success of these therapies. HCV eradication is predicted to decrease the mortality associated with coinfection and reduce the toxicity of HIV treatment. ©2007 Pulsus Group Inc. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Côté, P., Baril, J. G., Hébert, M. N., Klein, M., Lalonde, R., Poliquin, M., … Piché, A. (2007). Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals. Canadian Journal of Infectious Diseases and Medical Microbiology. Hindawi Limited. https://doi.org/10.1155/2007/631054
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.